Target intelligence / Profile preview

Mycoplasma-specific membrane glycolipid antigen (MP glycolipid)

Target
MP glycolipid
Molecular classification
Glycolipid, Antigen, Bacterial antigen
01

Overview

Mycoplasma-specific membrane glycolipid antigens are a group of highly immunogenic molecules located on the surface of Mycoplasma species, most notably Mycoplasma pneumoniae (Waites & Talkington, 2004, Clinical Microbiology Reviews). These glycolipids, which include structures such as galactosyl diglyceride and glucosyl diglyceride, play a critical role in the structural integrity of the cell membrane and the interaction between the pathogen and the host immune system (Kuwahara et al., 2017, Journal of Biological Chemistry). During an infection, these antigens trigger a robust antibody response, making them valuable targets for serological diagnostic tests, such as ELISA, to identify Mycoplasma-related respiratory infections (Meyer Sauteur et al., 2019, Journal of Clinical Microbiology). However, these glycolipids are also associated with significant clinical challenges due to molecular mimicry; antibodies produced against them can cross-react with host lipids in the nervous system or red blood cells, leading to extra-pulmonary complications like encephalitis or hemolytic anemia (Poddighe, 2017, Frontiers in Microbiology). Research into these antigens is vital for developing more accurate diagnostics and understanding the pathogenesis of Mycoplasma-induced autoimmune responses.

Other names
Mycoplasma pneumoniae glycolipidsGlyceroglycolipidsGalactosyl diglycerideGlucosyl diglycerideMycoplasma membrane lipids
02

Mechanism of action

Binding of specific antibodies to glycolipid epitopes facilitates pathogen neutralization, opsonization, and diagnostic detection.

03

Biological functions

Cell membrane organizationImmune responseHost-pathogen interactionImmune modulation
04

Disease associations

InfectionAtypical pneumoniaEncephalitisGuillain-Barré syndromeHemolytic anemiaInflammation
05

Safety considerations

Molecular mimicry leading to autoimmune cross-reactivityRisk of neurological complicationsRisk of hematological complications
06

Interacting drugs

Anti-Mycoplasma pneumoniae monoclonal antibodies

1 more in the full profile.

07

Biomarkers

Anti-glycolipid IgM antibodyAnti-glycolipid IgG antibody

Beyond the preview

Go deeper on Mycoplasma-specific membrane glycolipid antigen (MP glycolipid).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycoplasma-specific membrane glycolipid antigen (MP glycolipid).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call